The role of statins in stroke

Internal and Emergency Medicine, 05/23/2011

Paliani U et al.– In primary prevention, statins are effective both when low–density lipoprotein (LDL) is raised and when hs–CRP is elevated. In secondary prevention, an absolute reduction of recurrent stroke can be obtained with statins, with a number needed to treat at 5 years of 45.

  • Evidence from epidemiological studies examining a relationship between cholesterol level and stroke is less than definitive, there is a compelling evidence from the clinical therapy trials primarily designed to examine the coronary benefits of statins that statin therapy also causes a reduction in the risk of stroke.
  • Even though a stroke does not have the same exact pathophysiology as a heart attack, specific trials in stroke patients confirm advantages and risks of statin therapy in this kind of population.

Print Article Summary Cat 2 CME Report